Compare Moderna, Inc. (MRNA) vs Southern Company (SO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Southern Company — how do they compare? Moderna, Inc. trades at $137.18 (market cap $56.02B), while Southern Company trades at $88.67 (market cap $102.37B). The key difference: Southern Company is the larger of the two by market cap, and Southern Company pays a 3.42% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | SO | |
|---|---|---|
Market Cap | $56.02B | $102.37B |
Sector | Health | Utilities |
52-Week High | $174.38 | $99.72 |
52-Week Low | $22.36 | $84.08 |
Enterprise Value | $52.17B | $176.47B |
Dividend Yield | — | 3.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $140.33, down 3.59% on the day, but maintains a bullish technical signal with support at $138 and resistance at $145. Recent positive phase 3 cancer vaccine trial results have driven significant stock appreciation, though financials show declining revenue and negative net income margins. The company has beaten EPS estimates for the last three quarters, with Q3 2026 results pending.
The outlook is mixed; promising clinical developments in oncology offer long-term growth potential, but high valuation multiples and persistent losses pose risks. Analyst consensus is cautious with a $90.08 price target below the current price, reflecting concerns over profitability and competitive pressures in the mRNA therapeutics space.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Southern Company
Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.
Read more on SO →
